STAT3 and cancer: IL-6 signaling is mediated by the IL-6 receptor (IL-6R) and the signal transducer and activator of transcription 3 (STAT3), and dysregulation of this pathway has been implicated in the pathogenesis of several diseases, including cancer and autoimmune disorders.